Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.

Abstract

This combined modality therapy has been well tolerated and has been associated with high response and resectability rates in both stage IIIA and stage IIIB non-small-cell lung cancer. Current survival is significantly better than survivorship among historical control patients and provides a firm basis for subsequent phase III clinical trials.

References

Page 1

	Year	Citations
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert, New England Journal of Medicine	1990	1.2K
Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group Carlos A. Perez, Thomas F. Pajak, Philip Rubin, Cancer Adaptive RadiotherapyTen FractionsRadiation TherapyMedicineCancer Recurrence	1987	604
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. James D. Cox, N. Azarnia, Roger W. Byhardt, Journal of Clinical Oncology Surgical OncologyTreatment VerificationRadiation MedicineOncologyMetronomic Therapy	1990	471
The Role of Surgery in N2 Lung Cancer Nael Martini, Betty J. Flehinger Surgical Clinics of North America Surgical OncologyN2 Lung CancerMedicineBronchial NeoplasmThoracic Surgery	1987	428
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group Carlos A. Perez, Kenneth Stanley, Graham Grundy, Cancer Irradiation TechniqueTumor ControlPathologyProtocol ComplianceTreatment Verification	1982	399
Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node Metastases Nael Martini, Betty J. Flehinger, Muhammad Zaman, Annals of Surgery Surgical OncologyAjc Staging SystemPathologySurgeryNon-oat Cell Carcinoma	1983	378
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. Joseph D. McCracken, Lalitha M. Janaki, John J. Crowley, Journal of Clinical Oncology Surgical OncologySouthwest Oncology GroupMetronomic ChemotherapyGliomaCancer Chemotherapy	1990	198
Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer L. Penfield Faber, C. Frederick Kittle, William H. Warren, The Annals of Thoracic Surgery Preoperative ChemotherapyRadiation TherapyMedicineCancer TreatmentPulmonary Blastoma	1989	184
Significance of Metastatic Disease in Subaortic Lymph Nodes G.A. Patterson, Diego Piazza, F.G. Pearson, The Annals of Thoracic Surgery MedicineHistopathologyPathologyLymphatic SystemLymphatic Disease	1987	176
The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0) Nael Martini, Mark G. Kris, Richard J. Gralla, The Annals of Thoracic Surgery Preoperative ChemotherapyMedicinePathologyBronchial NeoplasmCancer Treatment	1988	175

Page 1